Café Scientifique takes place on the first Tuesday evening of the month at Café Boscanova
Enjoy listening to a short talk from our guest speaker before engaging in debate and discussion around that topic.
We’ll be joined by Ediz Akcay on Tuesday 3 March 7:30-9pm (doors open at 6:30pm)
No need to book, make sure you get there early though as seats fill up fast!
The Dark Side of Personalisation: AI, Voice Recognition and Beyond
“I’m afraid I can’t do that…” – a famous line from 2001: A Space Odyssey, in which the AI software HAL rebels to take control of the spaceship. We are now far beyond the year 2001 and we already have our own AI-supported voice recognition devices in our pockets, houses, and cars, used by adults and children alike. Luckily, they do not rebel against our commands – yet. These devices bring advantages in convenience and accessibility, playing a song has never been easier, but at what cost? Join us to discuss the ethics of the many new ways that companies listen to, track and store information about us using voice recognition and AI.
If you have any questions please do get in touch
Find out more about Café Scientifique and sign up to our mailing list to hear about other research events: www.bournemouth.ac.uk/cafe-sci
Cafe Scientifique: The Dark Side of Personalisation
Café Sci Tuesday 1 March: Deep breathing to lower blood pressure










New HIV paper by BU PhD student
BU Annual Research Conference: Poster Exhibition Call for Applications
Vitae Three Minute Thesis (3MT®) Competition: Applications Now Open
3C Online Social: Thursday 26 March 1–2pm – Research Culture, Community & Can you Guess Who?
Four BU students at national midwifery conference
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ECR Funding Open Call: Research Culture & Community Grant – Application Deadline Friday 12 December
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease